UniProt ID | ATF2_HUMAN | |
---|---|---|
UniProt AC | P15336 | |
Protein Name | Cyclic AMP-dependent transcription factor ATF-2 | |
Gene Name | ATF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 505 | |
Subcellular Localization | Nucleus. Cytoplasm. Mitochondrion outer membrane. Shuttles between the cytoplasm and the nucleus and heterodimerization with JUN is essential for the nuclear localization. Localization to the cytoplasm is observed under conditions of cellular stress | |
Protein Description | Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro. In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type.. | |
Protein Sequence | MKFKLHVNSARQYKDLWNMSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARNDSVIVADQTPTPTRFLKNCEEVGLFNELASPFENEFKKASEDDIKKMPLDLSPLATPIIRSKIEEPSVVETTHQDSPLPHPESTTSDEKEVPLAQTAQPTSAIVRPASLQVPNVLLTSSDSSVIIQQAVPSPTSSTVITQAPSSNRPIVPVPGPFPLLLHLPNGQTMPVAIPASITSSNVHVPAAVPLVRPVTMVPSVPGIPGPSSPQPVQSEAKMRLKAALTQQHPPVTNGDTVKGHGSGLVRTQSEESRPQSLQQPATSTTETPASPAHTTPQTQSTSGRRRRAANEDPDEKRRKFLERNRAAASRCRQKRKVWVQSLEKKAEDLSSLNGQLQSEVTLLRNEVAQLKQLLLAHKDCPVTAMQKKSGYHTADKDDSSEDISVPSSPHTEAIQHSSVSTSNGVSSTSKAEAVATSVLTQMADQSTEPALSQIVMAPSSQSQPSGS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 (in isoform 4) | Phosphorylation | - | 10.83 | 28634120 | |
44 | Phosphorylation | TNEDHLAVHKHKHEM CCCCCEEEEECCCEE | 8.54 | 15105425 | |
46 | Ubiquitination | EDHLAVHKHKHEMTL CCCEEEEECCCEEEE | 47.99 | - | |
48 | Ubiquitination | HLAVHKHKHEMTLKF CEEEEECCCEEEEEE | 46.17 | 21890473 | |
48 | Ubiquitination | HLAVHKHKHEMTLKF CEEEEECCCEEEEEE | 46.17 | 21890473 | |
51 | Phosphorylation | VHKHKHEMTLKFGPA EEECCCEEEEEECCC | 5.49 | 18669648 | |
52 | Phosphorylation | HKHKHEMTLKFGPAR EECCCEEEEEECCCC | 24.66 | 22304920 | |
53 | Phosphorylation | KHKHEMTLKFGPARN ECCCEEEEEECCCCC | 4.11 | 18669648 | |
55 | Phosphorylation | KHEMTLKFGPARNDS CCEEEEEECCCCCCC | 18.65 | 18669648 | |
62 | Phosphorylation | FGPARNDSVIVADQT ECCCCCCCEEEECCC | 19.79 | 22322096 | |
69 | Phosphorylation | SVIVADQTPTPTRFL CEEEECCCCCCCHHH | 29.67 | 22322096 | |
71 | Phosphorylation | IVADQTPTPTRFLKN EEECCCCCCCHHHHC | 40.45 | 22322096 | |
73 | Phosphorylation | ADQTPTPTRFLKNCE ECCCCCCCHHHHCHH | 36.21 | 29255136 | |
77 | Ubiquitination | PTPTRFLKNCEEVGL CCCCHHHHCHHHCCC | 57.76 | - | |
90 | Phosphorylation | GLFNELASPFENEFK CCHHHHCCCCHHHHH | 42.62 | 25159151 | |
94 | Phosphorylation | ELASPFENEFKKASE HHCCCCHHHHHHCCH | 61.45 | 18669648 | |
97 | Acetylation | SPFENEFKKASEDDI CCCHHHHHHCCHHHH | 41.05 | 24179875 | |
97 | Ubiquitination | SPFENEFKKASEDDI CCCHHHHHHCCHHHH | 41.05 | - | |
98 | Phosphorylation | PFENEFKKASEDDIK CCHHHHHHCCHHHHH | 63.57 | 18669648 | |
100 | Phosphorylation | ENEFKKASEDDIKKM HHHHHHCCHHHHHHC | 50.90 | 23312004 | |
105 | Acetylation | KASEDDIKKMPLDLS HCCHHHHHHCCCCCC | 50.44 | 25953088 | |
112 | O-linked_Glycosylation | KKMPLDLSPLATPII HHCCCCCCCCCCHHH | 19.96 | 30059200 | |
112 | Phosphorylation | KKMPLDLSPLATPII HHCCCCCCCCCCHHH | 19.96 | 29255136 | |
116 | Phosphorylation | LDLSPLATPIIRSKI CCCCCCCCHHHHHCC | 23.78 | 23927012 | |
121 | Phosphorylation | LATPIIRSKIEEPSV CCCHHHHHCCCCCCC | 27.81 | 22817900 | |
127 | Phosphorylation | RSKIEEPSVVETTHQ HHCCCCCCCEEECCC | 41.91 | 26657352 | |
131 | Phosphorylation | EEPSVVETTHQDSPL CCCCCEEECCCCCCC | 20.26 | 28450419 | |
132 | Phosphorylation | EPSVVETTHQDSPLP CCCCEEECCCCCCCC | 12.20 | 25159151 | |
136 | O-linked_Glycosylation | VETTHQDSPLPHPES EEECCCCCCCCCCCC | 23.05 | 30059200 | |
136 | Phosphorylation | VETTHQDSPLPHPES EEECCCCCCCCCCCC | 23.05 | 30266825 | |
143 | Phosphorylation | SPLPHPESTTSDEKE CCCCCCCCCCCCCCC | 41.24 | 29978859 | |
144 | Phosphorylation | PLPHPESTTSDEKEV CCCCCCCCCCCCCCC | 28.76 | 29978859 | |
145 | Phosphorylation | LPHPESTTSDEKEVP CCCCCCCCCCCCCCC | 43.38 | 29978859 | |
146 | Phosphorylation | PHPESTTSDEKEVPL CCCCCCCCCCCCCCC | 43.81 | 29978859 | |
226 | O-linked_Glycosylation | LHLPNGQTMPVAIPA EECCCCCCCCEEEEC | 25.49 | 30059200 | |
234 | O-linked_Glycosylation | MPVAIPASITSSNVH CCEEEECCCCCCCCC | 22.50 | 30059200 | |
236 | O-linked_Glycosylation | VAIPASITSSNVHVP EEEECCCCCCCCCCC | 24.49 | 30059200 | |
238 | O-linked_Glycosylation | IPASITSSNVHVPAA EECCCCCCCCCCCCE | 33.93 | 30059200 | |
253 | Phosphorylation | VPLVRPVTMVPSVPG ECEEEECEECCCCCC | 18.35 | 26074081 | |
257 | Phosphorylation | RPVTMVPSVPGIPGP EECEECCCCCCCCCC | 29.54 | 26074081 | |
265 | Phosphorylation | VPGIPGPSSPQPVQS CCCCCCCCCCCCCCC | 61.64 | 29255136 | |
266 | Phosphorylation | PGIPGPSSPQPVQSE CCCCCCCCCCCCCCH | 30.59 | 26657352 | |
272 | Phosphorylation | SSPQPVQSEAKMRLK CCCCCCCCHHHHHHH | 39.49 | 29255136 | |
283 | O-linked_Glycosylation | MRLKAALTQQHPPVT HHHHHHHHCCCCCCC | 22.81 | 30059200 | |
283 | Phosphorylation | MRLKAALTQQHPPVT HHHHHHHHCCCCCCC | 22.81 | - | |
290 | O-linked_Glycosylation | TQQHPPVTNGDTVKG HCCCCCCCCCCCCCC | 38.98 | 30059200 | |
290 | Phosphorylation | TQQHPPVTNGDTVKG HCCCCCCCCCCCCCC | 38.98 | - | |
294 | O-linked_Glycosylation | PPVTNGDTVKGHGSG CCCCCCCCCCCCCCC | 26.05 | 30059200 | |
305 | Phosphorylation | HGSGLVRTQSEESRP CCCCCCCCCCCCCCC | 29.03 | 23927012 | |
307 | Phosphorylation | SGLVRTQSEESRPQS CCCCCCCCCCCCCCC | 42.59 | 23927012 | |
310 | Phosphorylation | VRTQSEESRPQSLQQ CCCCCCCCCCCCCCC | 45.25 | 23927012 | |
314 | Phosphorylation | SEESRPQSLQQPATS CCCCCCCCCCCCCCC | 30.72 | 23927012 | |
320 | Phosphorylation | QSLQQPATSTTETPA CCCCCCCCCCCCCCC | 33.03 | 23927012 | |
321 | Phosphorylation | SLQQPATSTTETPAS CCCCCCCCCCCCCCC | 35.12 | 23927012 | |
322 | Phosphorylation | LQQPATSTTETPASP CCCCCCCCCCCCCCC | 25.05 | 23927012 | |
323 | Phosphorylation | QQPATSTTETPASPA CCCCCCCCCCCCCCC | 37.31 | 23927012 | |
325 | Phosphorylation | PATSTTETPASPAHT CCCCCCCCCCCCCCC | 23.28 | 23927012 | |
328 | Phosphorylation | STTETPASPAHTTPQ CCCCCCCCCCCCCCC | 24.67 | 23927012 | |
332 | Phosphorylation | TPASPAHTTPQTQST CCCCCCCCCCCCCCC | 42.13 | 30278072 | |
333 | Phosphorylation | PASPAHTTPQTQSTS CCCCCCCCCCCCCCC | 11.97 | 30278072 | |
336 | Phosphorylation | PAHTTPQTQSTSGRR CCCCCCCCCCCCCCC | 26.20 | 23927012 | |
338 | Phosphorylation | HTTPQTQSTSGRRRR CCCCCCCCCCCCCHH | 28.11 | 23927012 | |
339 | Phosphorylation | TTPQTQSTSGRRRRA CCCCCCCCCCCCHHH | 25.94 | 23927012 | |
340 | Phosphorylation | TPQTQSTSGRRRRAA CCCCCCCCCCCHHHH | 35.23 | 23927012 | |
349 | Phosphorylation | RRRRAANEDPDEKRR CCHHHHCCCCHHHHH | 67.22 | 1661585 | |
357 | Acetylation | DPDEKRRKFLERNRA CCHHHHHHHHHHHHH | 59.33 | 17590016 | |
367 | Phosphorylation | ERNRAAASRCRQKRK HHHHHHHHHHHHHHH | 27.47 | 1661585 | |
374 | Acetylation | SRCRQKRKVWVQSLE HHHHHHHHHHHHHHH | 47.70 | 17590016 | |
386 (in isoform 2) | Ubiquitination | - | 57.63 | 21890473 | |
386 | Ubiquitination | SLEKKAEDLSSLNGQ HHHHHHHHHHHCCHH | 57.63 | 21890473 | |
409 | Ubiquitination | RNEVAQLKQLLLAHK HHHHHHHHHHHHHCC | 27.16 | 21890473 | |
409 | Ubiquitination | RNEVAQLKQLLLAHK HHHHHHHHHHHHHCC | 27.16 | 21890473 | |
409 | Ubiquitination | RNEVAQLKQLLLAHK HHHHHHHHHHHHHCC | 27.16 | 21890473 | |
409 (in isoform 1) | Ubiquitination | - | 27.16 | 21890473 | |
416 | Acetylation | KQLLLAHKDCPVTAM HHHHHHCCCCCCEEE | 56.25 | 26051181 | |
427 | Phosphorylation | VTAMQKKSGYHTADK CEEEHHHCCCCCCCC | 52.17 | 24275569 | |
429 | Phosphorylation | AMQKKSGYHTADKDD EEHHHCCCCCCCCCC | 11.77 | 24275569 | |
431 | Phosphorylation | QKKSGYHTADKDDSS HHHCCCCCCCCCCCC | 28.24 | 24247654 | |
437 | Phosphorylation | HTADKDDSSEDISVP CCCCCCCCCCCCCCC | 45.84 | 24275569 | |
438 | Phosphorylation | TADKDDSSEDISVPS CCCCCCCCCCCCCCC | 46.40 | 23898821 | |
442 | Phosphorylation | DDSSEDISVPSSPHT CCCCCCCCCCCCCCC | 40.05 | 24275569 | |
445 | Phosphorylation | SEDISVPSSPHTEAI CCCCCCCCCCCCHHC | 55.11 | 25159151 | |
446 | Phosphorylation | EDISVPSSPHTEAIQ CCCCCCCCCCCHHCC | 18.03 | 25159151 | |
449 | Phosphorylation | SVPSSPHTEAIQHSS CCCCCCCCHHCCCCC | 30.42 | 28348404 | |
455 | Phosphorylation | HTEAIQHSSVSTSNG CCHHCCCCCCCCCCC | 18.96 | 28348404 | |
456 | Phosphorylation | TEAIQHSSVSTSNGV CHHCCCCCCCCCCCC | 20.26 | 28348404 | |
458 | Phosphorylation | AIQHSSVSTSNGVSS HCCCCCCCCCCCCCC | 28.24 | 28348404 | |
459 | Phosphorylation | IQHSSVSTSNGVSST CCCCCCCCCCCCCCC | 24.85 | 29449344 | |
460 | Phosphorylation | QHSSVSTSNGVSSTS CCCCCCCCCCCCCCH | 24.87 | 29449344 | |
464 | Phosphorylation | VSTSNGVSSTSKAEA CCCCCCCCCCHHHHH | 29.33 | 29449344 | |
465 | Phosphorylation | STSNGVSSTSKAEAV CCCCCCCCCHHHHHH | 34.00 | 29449344 | |
466 | Phosphorylation | TSNGVSSTSKAEAVA CCCCCCCCHHHHHHH | 27.09 | 29449344 | |
467 | Phosphorylation | SNGVSSTSKAEAVAT CCCCCCCHHHHHHHH | 31.64 | 29449344 | |
472 | Phosphorylation | STSKAEAVATSVLTQ CCHHHHHHHHHHHHH | 4.49 | 15916964 | |
480 | Phosphorylation | ATSVLTQMADQSTEP HHHHHHHHHCCCCCC | 3.60 | 15916964 | |
484 | Phosphorylation | LTQMADQSTEPALSQ HHHHHCCCCCCHHHH | 34.97 | 30177828 | |
485 | Phosphorylation | TQMADQSTEPALSQI HHHHCCCCCCHHHHH | 40.11 | 30177828 | |
490 | Phosphorylation | QSTEPALSQIVMAPS CCCCCHHHHHEECCC | 21.70 | 22817900 | |
497 | Phosphorylation | SQIVMAPSSQSQPSG HHHEECCCCCCCCCC | 31.32 | 30177828 | |
498 | Phosphorylation | QIVMAPSSQSQPSGS HHEECCCCCCCCCCC | 32.56 | 22817900 | |
500 | Phosphorylation | VMAPSSQSQPSGS-- EECCCCCCCCCCC-- | 46.11 | 30177828 | |
503 | Phosphorylation | PSSQSQPSGS----- CCCCCCCCCC----- | 43.99 | 30177828 | |
505 | Phosphorylation | SQSQPSGS------- CCCCCCCC------- | 41.19 | 30177828 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
44 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
52 | T | Phosphorylation | Kinase | PRKCH | P24723 | Uniprot |
52 | T | Phosphorylation | Kinase | PRKCE | Q02156 | GPS |
53 | T | Phosphorylation | Kinase | MK14 | Q16539 | PhosphoELM |
53 | T | Phosphorylation | Kinase | MK08 | P45983 | PhosphoELM |
55 | T | Phosphorylation | Kinase | VRK1 | Q99986 | PhosphoELM |
62 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
62 | S | Phosphorylation | Kinase | VRK1 | Q99986 | Uniprot |
62 | S | Phosphorylation | Kinase | PRKACA | P00517 | GPS |
69 | T | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
69 | T | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
69 | T | Phosphorylation | Kinase | MAPK14 | P47811 | GPS |
69 | T | Phosphorylation | Kinase | P38A | Q16539 | PSP |
69 | T | Phosphorylation | Kinase | P38B | Q15759 | PSP |
69 | T | Phosphorylation | Kinase | MAPK9 | P45984 | GPS |
69 | T | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
71 | T | Phosphorylation | Kinase | MAPK8 | Q91Y86 | GPS |
71 | T | Phosphorylation | Kinase | PLK3 | Q9H4B4 | Uniprot |
71 | T | Phosphorylation | Kinase | MAPK14 | P47811 | GPS |
71 | T | Phosphorylation | Kinase | P38A | Q16539 | PSP |
71 | T | Phosphorylation | Kinase | P38G | P53778 | PSP |
71 | T | Phosphorylation | Kinase | P38B | Q15759 | PSP |
71 | T | Phosphorylation | Kinase | MAPK9 | P45984 | GPS |
71 | T | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
71 | T | Phosphorylation | Kinase | ERK1 | P27361 | PSP |
71 | T | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
73 | T | Phosphorylation | Kinase | VRK1 | Q99986 | Uniprot |
90 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
90 | S | Phosphorylation | Kinase | MAPK9 | P45984 | GPS |
90 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
116 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
121 | S | Phosphorylation | Kinase | PKCB | P05771 | PSP |
121 | S | Phosphorylation | Kinase | PKCA | P17252 | PSP |
121 | S | Phosphorylation | Kinase | PKCB ISO2 | P05771-2 | PSP |
322 | S | Phosphorylation | Kinase | KPCB | P05771 | PhosphoELM |
322 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
340 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
340 | S | Phosphorylation | Kinase | PRKCB | P68403 | GPS |
340 | S | Phosphorylation | Kinase | PRKCA | P17252 | Uniprot |
340 | S | Phosphorylation | Kinase | PRKCB | P05771 | Uniprot |
349 | S | Phosphorylation | Kinase | KPCB | P05771 | PhosphoELM |
349 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
367 | S | Phosphorylation | Kinase | PRKCA | P17252 | Uniprot |
367 | S | Phosphorylation | Kinase | PRKCB | P05771 | Uniprot |
367 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
367 | S | Phosphorylation | Kinase | PRKCB | P68403 | GPS |
472 | S | Phosphorylation | Kinase | ATM | Q13315 | PhosphoELM |
480 | S | Phosphorylation | Kinase | ATM | Q13315 | PhosphoELM |
490 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
498 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
62 | S | Phosphorylation |
| 15105425 |
69 | T | Acetylation |
| 10821277 |
69 | T | Phosphorylation |
| 10821277 |
69 | T | Phosphorylation |
| 9430721 |
71 | T | Acetylation |
| 10821277 |
71 | T | Phosphorylation |
| 10821277 |
71 | T | Phosphorylation |
| 9430721 |
73 | T | Phosphorylation |
| 15105425 |
121 | S | Phosphorylation |
| 15105425 |
490 | S | Phosphorylation |
| 15916964 |
498 | S | Phosphorylation |
| 15916964 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATF2_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00852 | Pseudoephedrine |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-69; THR-71 AND SER-112,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-69; THR-71; SER-90 ANDSER-112, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-69; THR-71 AND SER-112,AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-69; THR-71 AND SER-112,AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112, AND MASSSPECTROMETRY. | |
"Hyperosmotic stress-induced ATF-2 activation through Polo-like kinase3 in human corneal epithelial cells."; Wang L., Payton R., Dai W., Lu L.; J. Biol. Chem. 286:1951-1958(2011). Cited for: PHOSPHORYLATION AT THR-71, SUBCELLULAR LOCATION, AND MUTAGENESIS OFTHR-71. | |
"Growth factors can activate ATF2 via a two-step mechanism:phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69through RalGDS-Src-p38."; Ouwens D.M., de Ruiter N.D., van der Zon G.C., Carter A.P.,Schouten J., van der Burgt C., Kooistra K., Bos J.L., Maassen J.A.,van Dam H.; EMBO J. 21:3782-3793(2002). Cited for: PHOSPHORYLATION AT THR-69 AND THR-71. | |
"Selective activation of p38 mitogen-activated protein (MAP) kinaseisoforms by the MAP kinase kinases MKK3 and MKK6."; Enslen H., Raingeaud J., Davis R.J.; J. Biol. Chem. 273:1741-1748(1998). Cited for: PHOSPHORYLATION AT THR-69 AND THR-71. |